| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
Revenue  | 40 | 47 | 54 | 31 | 35 | 20 | 30 | 33 | 33 | 14 | 17 | 18 | 27 | 15 | 14 | 19 | 16 | 18 | 18 | 28 | 25 | 50 | 75 | 36 | 36 | 28 | 27 | 19 | 23 | 23 | 28 | 33 | 28 | 31 | 41 | 35 | 34 | 34 |
| Expenses | 35 | 37 | 30 | 28 | 42 | 19 | 25 | 27 | 28 | 14 | 20 | 19 | 25 | 15 | 14 | 47 | 22 | 14 | 15 | 21 | 19 | 20 | 32 | 23 | 25 | 21 | 21 | 23 | 19 | 20 | 24 | 26 | 26 | 26 | 36 | 29 | 29 | 29 |
| EBITDA | 4 | 9 | 24 | 3 | -7 | 2 | 5 | 5 | 5 | 0 | -3 | 0 | 2 | -0 | -0 | -28 | -5 | 4 | 3 | 7 | 6 | 30 | 42 | 14 | 10 | 7 | 6 | -4 | 3 | 3 | 4 | 7 | 2 | 4 | 5 | 6 | 5 | 4 |
| Operating Profit % | 10 % | 19 % | 13 % | 7 % | -21 % | 6 % | 16 % | 14 % | 9 % | -0 % | -32 % | -3 % | -4 % | -7 % | -5 % | -155 % | -43 % | 22 % | 17 % | 22 % | 21 % | 60 % | 56 % | 37 % | 28 % | 23 % | 19 % | -27 % | 13 % | 12 % | 13 % | 21 % | 7 % | 12 % | 12 % | 15 % | 12 % | 11 % |
| Depreciation | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 1 | 3 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 2 | 10 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 2 | 2 | 2 | 1 | 2 |
| Interest | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 5 | 4 | 1 | 2 | 1 | 3 | 2 | 2 | 11 | 6 | 6 | 7 | 7 | 6 | 7 | 6 | 5 | 3 | 3 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -2 | 3 | 18 | -3 | -14 | -4 | 1 | -3 | -0 | -4 | -7 | -3 | -2 | -4 | -4 | -41 | -13 | -4 | -5 | -2 | -3 | 21 | 33 | 7 | -2 | 1 | -1 | -10 | -3 | -2 | -1 | 3 | -2 | 2 | 3 | 4 | 3 | 1 |
| Tax | 0 | 0 | 0 | -3 | 3 | 0 | -0 | 0 | -0 | 0 | -0 | 0 | -9 | -1 | -1 | 1 | -1 | 1 | 0 | 0 | -4 | 2 | 5 | 1 | 13 | 0 | -0 | 0 | 0 | 0 | -0 | 2 | 1 | 1 | 1 | 1 | 1 | 0 |
| Net Profit | -2 | 3 | 18 | 0 | -17 | -4 | 1 | -3 | 0 | -4 | -7 | -3 | 8 | -3 | -3 | -41 | -12 | -5 | -6 | -2 | 1 | 20 | 28 | 6 | -15 | 1 | -0 | -10 | -3 | -2 | -1 | 2 | -2 | 1 | 2 | 3 | 2 | 1 |
| EPS in ₹ | -0.91 | 0.77 | 6.26 | 0.23 | -5.45 | -1.89 | 0.21 | -1.32 | 0.82 | 0.00 | -2.30 | -0.67 | 2.66 | -1.13 | -1.14 | -14.50 | -5.67 | -1.64 | -2.01 | -0.80 | 0.39 | 6.80 | 9.90 | 2.11 | -5.26 | 0.20 | -0.14 | -3.64 | -1.05 | -0.57 | -0.15 | 0.53 | -3.83 | 0.40 | 0.58 | 0.75 | 0.49 | 0.25 |
Lyka Labs
Lyka Labs
94.65
+0.03
(0.03%)
Key Fundamentals
Market Cap
337.70 Cr
EPS
2.22
PE Ratio
44.26
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
176.59
52 Week Low
91.58
PB Ratio
3.26
Debt to Equity
0.55
Sector
Pharmaceuticals Actual
Company News
View All News
Kunal Gandhi, a promoter of Lyka Labs Limited, acquired 13,50,000 equity shares (4.08% stake) through transmission from Narendra I. Gandhi (HUF). The transaction was completed on June 27, 2023. Following this acquisition, Gandhi's individual holding increased from 10,69,152 shares (3.23%) to 24,19,152 shares (7.31%). The total promoter group holding, including persons acting in concert such as Nehal N. Gandhi, Enai Trading and Investment Private Limited, and Lyka Generics Limited, remained unchanged at 56,97,161 shares (17.22%). The company's total equity share capital stands at 3,30,90,000 shares. Lyka Labs is listed on BSE and NSE.
Lyka Labs Limited received an update on its Scheme of Amalgamation proceedings at the National Company Law Tribunal (NCLT), Ahmedabad Bench. The NCLT granted the Income Tax Department an extension of 15 days to submit their reply, extending from the previously allocated 7 days. The extension was requested by the lead counsel for the Income Tax Department due to a recent change in legal representation, with the new counsel replacing Ms. Maithili Mehta and requiring additional time to receive instructions from the department. The next hearing is scheduled for November 6, 2025. The company received a copy of the NCLT order on October 10, 2025.
Lyka Labs Limited has scheduled a Board of Directors meeting for September 29, 2025. The meeting will consider the redemption of 1,08,570 unlisted 10% Cumulative Redeemable Preference Shares valued at Rs.100 each, totaling approximately Rs.1.09 crore. The board will also discuss the appointment of a Company Secretary and Compliance Officer, along with other business matters. The company has notified both BSE and NSE about the meeting agenda.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,690.00 | #1 4,09,422.50 | 39.40 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 55.79 | |
6,804.50 | 1,80,624.80 | 78.34 | 9,712.00 | 18.67 | 2,191 | 26.74 | 71.76 | |
3,575.00 | 1,22,798.20 | 61.33 | 11,539.40 | 6.99 | 1,911 | 19.91 | 49.65 | |
1,503.30 | 1,22,092.00 | 22.47 | 28,409.50 | 7.12 | 5,291 | 3.71 | 40.07 | |
1,200.00 | 99,819.80 | #1 17.40 | 33,741.20 | 16.73 | 5,725 | -0.38 | 35.00 | |
2,369.50 | 99,041.40 | 51.83 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 35.31 | |
971.70 | 98,716.60 | 20.95 | 23,511.00 | 18.55 | 4,615 | 2.60 | 39.75 | |
1,997.00 | 90,611.00 | 24.37 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 59.93 | |
5,664.00 | 67,297.20 | 28.84 | 13,458.30 | 3.70 | 2,216 | 21.39 | 64.54 | |
1,149.10 | 67,291.70 | 20.02 | 32,345.60 | 9.43 | 3,484 | -10.24 | 63.12 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
24.84 %
Net Income Growth
-403.85 %
Cash Flow Change
7.34 %
ROE
-299.48 %
ROCE
211.45 %
EBITDA Margin (Avg.)
-5.97 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 279 | 242 | 252 | 229 | 216 | 200 | 190 | 186 | 152 | 157 | 176 |
| Fixed Assets | 122 | 104 | 133 | 116 | 108 | 105 | 98 | 94 | 68 | 58 | 85 |
| Current Assets | 102 | 82 | 63 | 49 | 35 | 36 | 29 | 52 | 44 | 51 | 67 |
| Capital Work in Progress | 27 | 30 | 24 | 28 | 31 | 28 | 26 | 18 | 16 | 23 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 130 | 107 | 94 | 85 | 77 | 68 | 66 | 74 | 67 | 76 | 90 |
| Total Liabilities | 279 | 242 | 252 | 229 | 216 | 200 | 190 | 186 | 152 | 157 | 176 |
| Current Liabilities | 195 | 163 | 165 | 167 | 85 | 66 | 50 | 99 | 33 | 38 | 47 |
| Non Current Liabilities | 37 | 30 | 42 | 9 | 85 | 149 | 165 | 73 | 73 | 51 | 26 |
| Total Equity | 47 | 49 | 45 | 53 | 46 | -15 | -25 | 14 | 46 | 68 | 104 |
| Reserve & Surplus | 20 | 22 | 16 | 21 | 14 | -43 | -55 | -15 | -3 | 26 | 68 |
| Share Capital | 23 | 23 | 22 | 28 | 28 | 29 | 29 | 29 | 31 | 33 | 36 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 4 | -1 | -0 | -3 | -1 | 9 | -3 | 10 | -5 | -6 | -5 |
| Investing Activities | 37 | 17 | -13 | -3 | -4 | -0 | -0 | -6 | 7 | -10 | -12 |
| Operating Activities | 27 | 12 | 31 | 11 | 27 | 5 | 9 | 79 | 9 | 2 | 2 |
| Financing Activities | -60 | -30 | -19 | -10 | -23 | 3 | -12 | -63 | -22 | 2 | 5 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Apr 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Apr 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 19.88 % | 19.88 % | 20.00 % | 20.04 % | 47.79 % | 47.80 % | 47.59 % | 47.59 % | 51.00 % | 54.56 % | 54.58 % | 54.81 % | 54.81 % | 54.81 % | 58.10 % | 58.10 % | 58.10 % | 58.10 % | 58.16 % | 58.16 % | 58.16 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.18 % | 0.00 % | 0.17 % | 0.16 % | 0.15 % | 0.15 % | 0.15 % | 0.23 % | 0.16 % | 0.18 % |
| DIIs | 0.47 % | 0.47 % | 1.85 % | 0.47 % | 1.19 % | 4.00 % | 4.00 % | 4.00 % | 3.74 % | 3.09 % | 0.41 % | 0.41 % | 0.41 % | 0.88 % | 0.82 % | 0.75 % | 0.67 % | 0.67 % | 0.67 % | 0.67 % | 0.67 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 62.34 % | 60.25 % | 59.72 % | 33.35 % | 37.27 % | 38.86 % | 37.71 % | 38.77 % | 35.08 % | 33.03 % | 35.56 % | 35.49 % | 34.32 % | 33.90 % | 31.48 % | 31.67 % | 32.06 % | 32.13 % | 31.18 % | 31.41 % | 31.52 % |
| Others | 17.31 % | 19.40 % | 18.43 % | 46.14 % | 13.75 % | 9.35 % | 10.70 % | 9.64 % | 10.18 % | 9.33 % | 9.45 % | 9.11 % | 10.46 % | 10.23 % | 9.44 % | 9.32 % | 9.02 % | 8.95 % | 9.76 % | 9.61 % | 9.48 % |
| No of Share Holders | 19,350 | 22,120 | 20,672 | 27,720 | 26,220 | 26,969 | 28,433 | 28,515 | 26,820 | 26,870 | 27,202 | 26,652 | 26,422 | 25,717 | 25,699 | 25,716 | 28,943 | 29,099 | 28,472 | 28,189 | 27,743 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 12 Nov 2025 |  Quarterly Result Announcement | NA | 12 Nov 2025 | 94.77 | 94.72 |
| 17 Feb 2023 |  Extraordinary General Meeting | NA | 17 Feb 2023 | 148.15 | 123.50 |
| 20 Feb 2024 | Extraordinary General Meeting | NA | 20 Feb 2024 | 120.50 | 132.45 |
| 09 Aug 2024 |  Annual General Meeting | NA | 09 Aug 2024 | 112.85 | 115.20 |
| 12 Nov 2024 | Quarterly Result Announcement | NA | 12 Nov 2024 | 141.60 | 144.70 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 154.35 | 142.40 |
| 04 Mar 2025 | Extraordinary General Meeting | NA | 04 Mar 2025 | 144.65 | 100.90 |
| 26 May 2025 | Quarterly Result Announcement | NA | 26 May 2025 | 111.05 | 116.80 |
| 01 Aug 2025 | Quarterly Result Announcement | NA | 01 Aug 2025 | 114.45 | 116.40 |
| 01 Aug 2025 | Annual General Meeting | NA | 01 Aug 2025 | 111.70 | 116.40 |
Announcements
Board Meeting Intimation for Meeting To Be Held On 12Th November 2025
Oct 23, 2025
Oct 23, 2025Update On Scheme Of AmalgamationOct 11, 2025
Oct 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Intimation Of Redemption Of Unlisted 10% Cumulative Redeemable Preference SharesSep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 30, 2025
Sep 30, 2025Board Meeting Outcome for Outcome Of The Board MeetingSep 29, 2025
Sep 29, 2025Board Meeting Intimation for Intimation Of The Board Meeting - 29Th September 2025Sep 24, 2025
Sep 24, 2025Update On The Scheme Of AmalgamationSep 18, 2025
Sep 18, 2025Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 - UpdatesSep 05, 2025
Sep 05, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 01, 2025
Sep 01, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 29, 2025
Aug 29, 2025Update On Scheme Of AmalgamationAug 08, 2025
Aug 08, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 04, 2025
Aug 04, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 02, 2025
Aug 02, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerAug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Change in ManagementAug 01, 2025
Aug 01, 2025ResultsAug 01, 2025
Aug 01, 2025Board Meeting Outcome for OutcomeAug 01, 2025
Aug 01, 2025Board Meeting Intimation for To Consider And Approve The Unaudited Standalone And
Consolidated Financial Results Of The Company For The First Quarter Ended 30Th June 2025.Jul 21, 2025
Jul 21, 2025Update On The Scheme Of AmalgamationJul 11, 2025
Jul 11, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Jul 09, 2025Letter Sent To Shareholders- U/R 36 (1)(B) Of The LODRJul 09, 2025
Jul 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 09, 2025
Jul 09, 2025Reg. 34 (1) Annual Report.Jul 08, 2025
Jul 08, 2025Notice Of The 46Th AGM Of The Company For FY 2024-25 Is Enclosed.Jul 08, 2025
Jul 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJul 04, 2025
Jul 04, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 30, 2025
Jun 30, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jun 27, 2025
Jun 27, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 26, 2025
Jun 26, 2025Closure of Trading WindowJun 23, 2025
Jun 23, 2025Update On The Scheme Of AmalgamationJun 13, 2025
Jun 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2025
May 28, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
May 27, 2025Approved The Appointment Of M/S. Kaushal Doshi & Associates Practicing Company Secretaries (Firm Registration No. 106609 ) As The Secretarial Auditor Of The Company For A Period Of Five Consecutive Years Subject To Approval Of The Shareholders At The EnsuMay 26, 2025
May 26, 2025Appointment Of Cost Auditor
A. Approved The Appointment Of M/S. Rajaram M Walavalakar & Co. (FRN: 003584 ) Cost Accountants As The Cost Auditors Of The Company For The Financial Year Ended 31St March 2025 To Fill The Casual Vacancy Caused By The ResignaMay 26, 2025
May 26, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateMay 26, 2025
May 26, 2025Integrated Filing (Financial)May 26, 2025
May 26, 2025Audited Financial Results (Standalone & Consolidated) For The Quarter And Financial Year Ended
31St March 2025 And Statement Of Assets And Liabilities (Standalone And Consolidated) As At
31St March 2025 Alongwith Auditors Report (Standalone And ConsolidMay 26, 2025
May 26, 2025Board Meeting Outcome for Intimation Under Regulations 30 And 33 Of The SEBI (Listing Obligations And
Disclosure Requirements) Regulations 2015 (The SEBI Listing Regulations)May 26, 2025
May 26, 2025Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Update On The Scheme Of AmalgamationMay 22, 2025
May 22, 2025Board Meeting Intimation for To Consider And Approve The Following:
I. Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended 31St March 2025; And
Ii. Proposal For Lyka Labs Limited Employee StockMay 14, 2025
May 14, 2025Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And
Disclosure Requirements) Regulations 2015 - Resignation Of Cost AuditorMay 09, 2025
May 09, 2025Roznama Order Of The City Civil Court Mumbai Regarding Disputed ClaimMay 08, 2025
May 08, 2025-Intimation For Change Of Email Id And Website Details Of Registrar & Share Transfer AgentApr 18, 2025
Apr 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 10, 2025
Apr 10, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 08, 2025
Apr 08, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 04, 2025
Apr 04, 2025Update On The Scheme Of AmalgamationApr 01, 2025
Apr 01, 2025Technical Indicators
RSI(14)
Neutral 45.46
ATR(14)
Less Volatile 2.84
STOCH(9,6)
Oversold 17.25
STOCH RSI(14)
Neutral 41.85
MACD(12,26)
Bullish 0.17
ADX(14)
Weak Trend 14.15
UO(9)
Bullish 25.09
ROC(12)
Uptrend And Accelerating 0.13
WillR(14)
Neutral -78.70
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
